For personal use only. Investor Presentation September 2015

Transcription

1 Investor Presentation September 2015

2 Pro Medicus (ASX:PME) listed company Visage Imaging wholly owned subsidiary Offices in three continents Over 40 Software Engineers EU Headquarters / R&D Berlin, Germany US Headquarters San Diego, CA Group Headquarters Melbourne

3 PME Ltd Pro Medicus (RIS) Visage 7 * Product Suite OEM Visage RIS * Pro Medicus.net

4 visageimaging.com number 1 in. For personal use only

5 Current Imaging Technology Massive Data explosion Higher image density - CT leaps from 64 Slices to 256 and now 640 3T MRI over 4 times the dataset of 1.5T Functional Imaging eg PET scan often > 1.5 to 2 Gig Gigabytes Digital Breast Tomosynthesis (DBT) files can be over 4 to 6 Gigabytes Prior examinations multiply the problem

6 Deconstructed PACS Architecture

7 Deconstructed PACS - VNA Radiology Gastroenterology Urology Oncology Cardiology Neurology

8 Enterprise Viewer VNA use surging VNA's projected to store 31% of new imaging studies worldwide by 2016 InMedica, May 2012 Of late, imaging IT has been a "barren" field of technology innovation Reiner & McKinley, JDI, June 2012 No single vendor will do Enterprise Imaging 2012, KLAS Image sharing most important capability for institutions that have adopted VNA Katalus Advisors, June D imaging into the workflow of the radiology department effectively Advanced Visualization 2011, KLAS More providers forming Enterprise Imaging Strategies, w/goal of getting "the right image to the right place at the right time" KLAS, July 2012

9 Introducing Visage 7

10 Opportunities - North America Worlds largest market PACS market estimated at > US $1.5B pa and growing Paradigm shift to Deconstructed PACS best in breed approach Market fragmented - in process of consolidating Visage - recognised leader in Enterprise viewing & 3D PACS technologies. Visage ideally suited to capitalise on market trends

11 North America Four deals in the last 10 months network affect Growing pipeline. Opportunities spread across key market segments: Enterprise Hospitals Imaging Centres Teleradiology/Remote reading groups Industry consolidation to create further opportunities.

12 North America vrad For personal use only

13 VISN 23 For personal use only

14 Large US Health System May 2014 >$20M minimum over 6 years Visage 7.0 to be used for all diagnostic interpretation and clinical (referrer distribution) Operational (transaction based) model Significant upside as Visage technology is rolled out Implementation still in process. To be completed this FY.

15 WellSpan Health November 2014 $8M - 7 year deal Visage 7.0 to be used for all diagnostic interpretation and clinical (referrer distribution) Operational (transaction based) model Validation deconstructed model rapidly gaining momentum Comes on top of other recent US wins

16 Zwanger Pesiri January 2015 $5M - 5 year deal Operational (transaction based) model Key player in Private/Imaging centre market Fully up and running Technology delivering significant benefits Excellent East Coast reference site

17 UF Medical System April 2015 $9.5M - 7 year deal Visage 7.0 to be used for all diagnostic interpretation and clinical (referrer distribution) Hybrid operational and capital model Comes on top of other recent US wins University Hospital/Academic reference site. Implementation proceeding well.

18 Allegheny (AHN) Sept 2015 $11.0M - 5 year deal Visage 7.0 to be used for all diagnostic interpretation and clinical (referrer distribution) Transaction based model 4 th major win in under 12 months. Affiliated with Blue Cross/Blue Shield

19 Operational (Transaction) Model Alternative to capital model Favoured in recent US contracts Model based on guaranteed minimums Contracted minimums increase to >$60M Upside as client examination volumes grow Annuity style revenue stream greater predictability

20 Margin Expansion Highly scalable offering No Capex (HW) SW only model Training & Installation charged as Professional services Relatively Fixed Cost base Margin growth as footprint increases

21 Growth Drivers Transaction growth (above minimums) from existing clients Expand current footprint via new deals Margin expansion with future contracts Continue to build out pipeline Introduce new products Extend to other markets

22 Investor Presentation September 2015